[go: up one dir, main page]

AU2002342657A1 - Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i - Google Patents

Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i

Info

Publication number
AU2002342657A1
AU2002342657A1 AU2002342657A AU2002342657A AU2002342657A1 AU 2002342657 A1 AU2002342657 A1 AU 2002342657A1 AU 2002342657 A AU2002342657 A AU 2002342657A AU 2002342657 A AU2002342657 A AU 2002342657A AU 2002342657 A1 AU2002342657 A1 AU 2002342657A1
Authority
AU
Australia
Prior art keywords
peptides
inhibitors
terminal
dipeptidyl peptidase
hydroxylamino group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002342657A
Inventor
Hans-Ulrich Demuth
Ulrich Heiser
Andre Niestroj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vivoryon Therapeutics AG
Original Assignee
Probiodrug AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiodrug AG filed Critical Probiodrug AG
Publication of AU2002342657A1 publication Critical patent/AU2002342657A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002342657A 2001-09-06 2002-09-06 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i Abandoned AU2002342657A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10143840A DE10143840A1 (en) 2001-09-06 2001-09-06 New acylated hydroxamates useful for the treatment of e.g. wound healing
DE10143840.0 2001-09-06
PCT/EP2002/010020 WO2003022871A2 (en) 2001-09-06 2002-09-06 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i

Publications (1)

Publication Number Publication Date
AU2002342657A1 true AU2002342657A1 (en) 2003-03-24

Family

ID=7698010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342657A Abandoned AU2002342657A1 (en) 2001-09-06 2002-09-06 Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i

Country Status (5)

Country Link
EP (1) EP1423410A2 (en)
JP (1) JP2005511505A (en)
AU (1) AU2002342657A1 (en)
DE (1) DE10143840A1 (en)
WO (1) WO2003022871A2 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050122220A (en) 2003-03-25 2005-12-28 다케다 샌디에고, 인코포레이티드 Dipeptidyl peptidase inhibitors
US7638638B2 (en) 2003-05-14 2009-12-29 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
DK1633702T3 (en) * 2003-05-30 2008-11-10 Prozymex As protease inhibitors
US7790736B2 (en) 2003-08-13 2010-09-07 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7790734B2 (en) 2003-09-08 2010-09-07 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CN102079743B (en) 2004-03-15 2020-08-25 武田药品工业株式会社 dipeptidyl peptidase inhibitor
EP1745292A2 (en) * 2004-04-28 2007-01-24 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
US7687638B2 (en) 2004-06-04 2010-03-30 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7872124B2 (en) 2004-12-21 2011-01-18 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
DOP2006000008A (en) 2005-01-10 2006-08-31 Arena Pharm Inc COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
EP1942898B2 (en) 2005-09-14 2014-05-14 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
CN102675221A (en) 2005-09-16 2012-09-19 武田药品工业株式会社 Intermediate in method for preparing pyrimidinedione derivative
CA2618488C (en) 2006-04-11 2010-07-13 Arena Pharmaceuticals, Inc. Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
PE20071221A1 (en) 2006-04-11 2007-12-14 Arena Pharm Inc GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
AR077642A1 (en) 2009-07-09 2011-09-14 Arena Pharm Inc METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
WO2011127051A1 (en) 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
AU2011305525B2 (en) 2010-09-22 2016-08-18 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140066369A1 (en) 2011-04-19 2014-03-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
GB201415598D0 (en) 2014-09-03 2014-10-15 Univ Birmingham Elavated Itercranial Pressure Treatment
AU2016229982B2 (en) 2015-03-09 2020-06-18 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
SG11201909046XA (en) 2017-04-03 2019-10-30 Coherus Biosciences Inc PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY
CN113292465B (en) * 2021-06-17 2022-11-08 贵州医科大学 A kind of cysteine derivative and its synthetic method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016751A1 (en) * 1996-11-22 2001-08-01 Athena Neurosciences Inc METHOD FOR INHIBITING THE RELEASE OF THE BETA-AMYLOID PEPTIDE IN A CELL, PHARMACEUTICAL COMPOSITION AND USEFUL COMPOUNDS IN THIS METHOD
DE19834610A1 (en) * 1998-07-31 2000-02-24 Probiodrug Ges Fuer Arzneim New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders

Also Published As

Publication number Publication date
DE10143840A1 (en) 2003-03-27
EP1423410A2 (en) 2004-06-02
WO2003022871A3 (en) 2003-11-13
WO2003022871A2 (en) 2003-03-20
JP2005511505A (en) 2005-04-28

Similar Documents

Publication Publication Date Title
AU2002342657A1 (en) Peptides having a c- terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
AU2002360732A1 (en) Change inhibitors of dipeptidyl peptidase iv
PL370220A1 (en) Inhibitors of dipeptidyl peptidase iv
AU2003286776A1 (en) Novel inhibitors of dipeptidyl peptidase iv
IL151588A0 (en) Inhibitors of dipeptidyl peptidase iv
AU2003207881A1 (en) Dipeptidyl peptidase inhibitors
AU2002342675A1 (en) Pyrazole derivatives as glycine transporter inhibitors
AU2002211663A1 (en) Nf-$g(k)b inhibitors
AU2002240057A1 (en) Therapeutic peptides for demyelinating conditions
AU2002365928A1 (en) Inhibitors of autoinducer transporters
AU2002320460A1 (en) Calcineurin modulators
AU2003246614A1 (en) Novel use of lipopeptide preparations
GB0117011D0 (en) Peptide barrels
HK1066227A (en) Peptides having a c-terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i
AU2002342682A1 (en) Protease inhibitors
AU2003304374A1 (en) Peptide inhibitors of beta-lactamases
HK1065532A (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
AU2002315472A1 (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
HK1068553A (en) Inhibitors of dipeptidyl peptidase iv
AU2002310050A1 (en) Peptide synthesis method
HK1057561A (en) Peptides as met-ap2 inhibitors
HK1059791A (en) Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis
AU2003245060A1 (en) Peptidic thrombin inhibitor compound
AUPR975701A0 (en) Dipeptidyl peptidase-iv inhibitor
AU2002328853A1 (en) Carcinoma-related peptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase